Pre-conception planning is a systems read on the internal and external conditions that decide whether a pregnancy can initiate, sustain, and develop well. The menstrual cycle is the primary data source, the hormones are the readout, and the metabolic, immune, and environmental context is the ground everything stands on. Most of what shows up in a pre-conception workup is a collection of individually minor, collectively decisive readings that quietly explain why nothing has happened yet.

This guide covers female reproductive physiology by design; male factor, though, accounts for roughly 40-50% of infertility and is routinely diagnosed late because the assumption is that the female workup is the one that needs running. A semen analysis is a short investment that shifts the whole diagnostic frame if it comes back abnormal. Both partners get the workup - A Field Guide to Male Fertility carries the male half. Both partners get the environmental and nutritional work.

Before you begin

Is this for you?

This guide is for

Women actively trying to conceive or planning to within the next one to three years
Women with unexplained cycle irregularity, recurrent miscarriage, or a diagnosis of polycystic ovary syndrome (PCOS), endometriosis, or diminished ovarian reserve
Women who want to understand their own reproductive physiology well enough to ask better questions and make better decisions - whether or not a pregnancy is imminent
Couples who want to address the groundwork before conception - metabolic, environmental, and nutritional - rather than reactively after

This guide is not for

Anyone expecting it to replace an in vitro fertilization (IVF), ovulation-induction, or fertility-treatment program - it builds the biological conditions that support fertility and runs alongside those treatments, but it isn't itself a clinical treatment protocol
Women who are already pregnant - several items here, including melatonin, dehydroepiandrosterone (DHEA), and some botanicals, are pre-conception only and aren't for use once trying to conceive or pregnant without provider oversight
Anyone wanting a diagnosis or a prescription by mail - the labs and protocol here are built to be brought to a clinician, not to replace one

This guide describes mechanisms, flags the levers that matter most, and tells you what to track. Agency stays with you - and the whole picture still benefits from a clinical eye looking at the system rather than ordering the standard panel and waiting for something to fall out of range.

The mechanism

The reproductive axis

The reproductive story starts before you were born. By the end of fetal development your ovaries are already stocked with essentially all the follicles you'll ever have - on the order of a few million oocytes generated in utero, declining from there. There's emerging research on ovarian stem cells and intra-ovarian platelet-rich plasma (PRP) as stimulants for new follicle generation, but any contribution appears minimal by comparison and isn't established practice. The eggs you're working with now were made while your mother was pregnant with you, so a pregnancy is also the developmental environment the next generation will sit inside.

The working system is the hypothalamic-pituitary-ovarian (HPO) axis. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses; the pituitary answers with follicle-stimulating hormone (FSH) and luteinizing hormone (LH); those gonadotropins drive the ovary to mature follicles and produce estradiol, with progesterone following from the corpus luteum only after ovulation; and the ovarian hormones feed back to restrain the pulse. A disruption anywhere along that chain shows up as an irregular or absent cycle - and where it sits decides what helps.

An irregular or absent cycle can come from a break at any level of this chain. Which level is what the cycle pattern and the hormone panel read out - and it decides whether the fix is metabolic, hypothalamic, or ovarian.

The axis first switches on at thelarche - the start of breast development, reflecting the first meaningful estrogen production - with menarche and then reliable ovulation following over the next two to three years on average. That onset is tightly regulated by body-fat stores and leptin, which is why both extremes of body composition, too lean and too heavy, can distort the timing and coordination of reproductive function. That sensitivity to energy availability never goes away - it's the same signal the system reads before every cycle.

The primary data source

Reading the cycle

The cycle has four phases, each with a distinct hormonal signature and each capable of going wrong in ways that accumulate downstream.

The follicular phase. As the previous luteal phase ends, circulating hormones drop and release the brake on gonadotropin release. FSH and LH rise, the endometrium loses its growth signal and sloughs - that's menses, which should run about three to five days with the heaviest flow in the first half. By roughly day seven, FSH and local growth factors have recruited a cohort of follicles to compete, and it's the small growing follicles across the ovary that secrete anti-Mullerian hormone (AMH) - continuously, and largely independent of cycle day, which is why it reflects the size of the remaining follicle pool and is the workhorse blood marker of ovarian reserve. As the dominant follicle grows, its estradiol and inhibin B rise and suppress FSH - so only follicles that no longer need FSH support survive the cut, and the rest atrophy. Estradiol then peaks, the brake lifts, the LH surge fires, and ovulation is triggered.

Extended or very heavy menses - say five to six days of heavy bleeding followed by days of spotting - is common, but it isn't what the cycle is built to do. A dragged-out follicular phase can mean oocyte recruitment and maturation don't finish before ovulation is due, which can show up downstream as luteal phase deficiency or anovulation. The same slow recruitment can surface as either one.

Ovulation and the luteal phase. The LH surge tells the chosen oocyte to resume division, detach from the follicular scaffolding, and rupture the follicle wall; the oocyte then travels down the fallopian tube. The ruptured follicle becomes the corpus luteum, which secretes progesterone to shift the uterine lining into its secretory, implantation-ready state. If the follicle wasn't large enough at rupture, or the corpus luteum can't sustain progesterone, implantation and early pregnancy maintenance become difficult. If an embryo implants, it secretes human chorionic gonadotropin (hCG), which keeps the corpus luteum producing progesterone through early pregnancy - and that hCG is what a pregnancy test detects. The corpus luteum only has to hold the line for the first weeks: around weeks 7 to 9 the placenta takes over progesterone production - the luteal-placental shift - which is why early progesterone support can matter while later support usually does not.

The fertile window opens several days before ovulation and closes just after it. A urine LH strip predicts ovulation by catching the pre-ovulatory surge - it can't confirm release happened. The one test that confirms ovulation is a mid-luteal serum progesterone.

Prediction is not confirmation. Urine LH strips, basal body temperature, and cervical-mucus changes help you time intercourse, but none of them prove an egg was released. LH strips detect the surge that precedes ovulation; a temperature shift and secretory-phase signs come after it but are indirect. To confirm ovulation occurred in a given cycle, the test is a mid-luteal serum progesterone (drawn about seven days after suspected ovulation, often day 19-21) showing the expected rise. This distinction matters most in cycles that look regular on the surface but aren't releasing an egg.

A note on nonsteroidal anti-inflammatory drugs (NSAIDs) around ovulation. NSAIDs - ibuprofen, naproxen, aspirin at therapeutic doses - inhibit cyclooxygenase (COX), and COX-driven prostaglandin signaling is part of what ruptures the follicle. Chronic or high-dose NSAID use in the days around ovulation can blunt or delay rupture, occasionally producing a luteinized unruptured follicle - where the LH surge fires and the corpus luteum forms but the oocyte never releases. This is reversible on discontinuation and can explain cycle-to-cycle difficulty in women who reach for NSAIDs habitually. Acetaminophen doesn't share this mechanism and is the cleaner choice when something is needed.

The oocyte

Egg quality and the age question

Oocytes have been arrested since fetal development and don't fully "work" until they're called up for maturation - so in theory age shouldn't degrade them. In practice it does, and the proposed mechanisms are disrupted DNA-repair machinery, dysfunction in chromatid cohesion, and accumulated environmental and physiologic insults to the cell over time. That's compounded by age-related change across the whole system - hormonal regulation, uterine responsivity, fallopian-tube cilia function, systemic inflammation, structural integrity. The oocyte doesn't age in isolation; the environment it matures in ages with it.

Egg quality isn't fixed at any given age: several of its inputs are modifiable, and the maturation window that matters is roughly the ninety days before ovulation. That's the window most of the cellular support in this guide is aimed at.

Age and lifetime exposure set a baseline you can't fully rewind - but mitochondrial function, oxidative balance, and the metabolic environment are inputs you can move in the ninety days before conception, which is why the cellular-support tier exists.

If you want a family but the timing isn't right - the partner isn't there, the circumstances aren't stable - egg banking is worth a serious conversation. Earlier isn't automatically better, though: oocyte chromosomal-error rates follow a U-shaped curve - modestly higher in the very young, lowest in the late 20s, then climbing steadily with age. The window that balances quality, quantity, and the odds you'll use the eggs runs from the late 20s into the mid-30s. Per-egg quality favors the earlier end, but once you weigh cost and the odds of needing them, the balance shifts toward the early-to-mid 30s - eggs banked very young are the ones most often never claimed. Wait past the mid-30s and both quantity and quality fall off, and finding that window closed is a grief of its own. Frozen eggs are insurance you hope not to need - worth having, at the right time. Where your own line sits depends on your reserve and your circumstances - a conversation for a reproductive endocrinologist while the option is widest.

Timing & transition

Tracking, timing, and coming off contraception

The axis, the cycle, and the egg all serve a narrow fertile window, so timing sits on top of everything else, and the tracking data you bring decides how precisely you can hit that window. The general consensus on optimal timing is intercourse every one to two days beginning around day five to seven of the cycle, increasing to daily in the one to two days immediately before ovulation and through ovulation itself. Semen quality - motility, morphology, count - degrades with more than two to three days of abstinence, so more frequent intercourse tends to produce both better sperm quality and better pregnancy rates.

For tracking, a combined read of estradiol, progesterone, LH, and FSH metabolites across the cycle (some at-home systems track all four) tells you more than a single LH strip, because you're watching the whole hormonal arc rather than guessing at one point. Simpler methods each carry a caveat: basal body temperature (BBT) rises after ovulation because progesterone shifts the hypothalamic temperature setpoint, so it's a post-hoc confirmation of a pattern across cycles, not a way to time a single cycle in real time. Cervical mucus taking on a raw-egg-white consistency is the more actionable acute signal that the fertile window is open.

Coming off hormonal contraception. A meaningful fraction of women entering pre-conception planning are stopping contraception, and the return-to-cycling profile isn't uniform across methods - partly because the methods don't all act the same way.

A combined pill suppresses the HPO axis and stops ovulation - its placebo-week bleed is a withdrawal bleed, not a true period. A hormonal intrauterine device (IUD) acts mainly on the endometrium and a copper IUD is non-hormonal, so both often leave ovulation and hypothalamic signaling intact - with one caveat: the higher-dose 52mg hormonal IUD suppresses ovulation in roughly half of cycles during its first year, easing as it ages, so with a recent one, confirm ovulation rather than assume it. Return-to-cycling runs from one to three months for the pill to six to twelve-plus months for the depot injectable, which has no way to be accelerated.

The cycle that returns isn't always the cycle that was suppressed. Patterns that pre-dated contraception - PCOS, luteal phase deficiency, an anovulatory tendency - often re-emerge once the exogenous hormone clears, and they get attributed to the contraception when the contraception was masking them. Starting the blood work and the supplement foundation before discontinuation, not after, gives you a head start on whatever the contraception was masking.

The ground

The internal environment

Cycle tracking, timing, and the supplement protocol are what you build above ground; the internal environment is the ground itself, and if it's dysregulated, precise timing has little to act on. When the brain assesses whether conditions are suitable for a pregnancy, the primary signals it reads are metabolic and psychoneuroendocrine.

Stress and the psychoneuroendocrine dimension

Rates of depression in women experiencing infertility have been compared to those in serious-illness populations, and it's estimated that roughly one in eight couples have difficulty conceiving or sustaining a pregnancy. That burden is also mechanistically consequential. Chronic psychosocial stress elevates cortisol and suppresses the HPO axis through a well-documented pathway. In this arena the stress is rarely abstract: trying and failing to conceive mimics social defeat - the felt loss of a contest, sharpened each time a peer announces a pregnancy. It activates GRIEF, the brain's separation-distress circuitry, run not over a person but over an imagined child and a future that was supposed to have arrived. It activates RAGE, the response to a reward expected and then withheld - a dream perceived as lost. These are primal affective systems, not moods to be reasoned away, and running them without resolution is what holds corticotropin-releasing hormone (CRH) and cortisol high month after month. The organism assesses its own capacity to support a pregnancy, and when it reads the conditions as not-ready, it attenuates the reproductive signal through the same primitive circuit that governs reproductive resource allocation under strain. The mechanism is physiological, and it's part of why some women conceive naturally after letting go of the pressure that accompanied years of trying.

The internal environment of a pregnancy begins to be written before the pregnancy. Genes tied to stress resilience - cortisol-receptor function, serotonin signaling, neural growth factors - show epigenetic differences in children born to chronically stressed mothers. Work on the stress axis in the pre-conception window acts on the same hypothalamic signaling that drives the HPO axis.

Metabolic function

Leptin and adipokines communicate energy availability and body composition to the hypothalamus, and if that read is "not ready," the HPO axis is muted before anything else can happen. Two systems earn priority. First, blood sugar and insulin: even without obesity, dysregulated insulin and glucose disrupt cycling, ovulation, and oocyte health - PCOS is the clearest example, but metabolic dysfunction is implicated broadly, and if pregnancy occurs against that background, miscarriage, fetal-abnormality, and complication risks rise. The metabolic piece is worth working on now, alongside trying rather than ahead of it - with one exception: blood sugar in the diabetic range makes the pregnancy itself riskier until it's treated, so that one is for a clinician to see before conceiving. Second, thyroid: the thyroid and sex-hormone systems are interlinked enough to treat together as low-hanging fruit - thyroid hormones affect ovulation timing, implantation, premature-birth risk, and maternal mood, and a full thyroid panel is worth running as part of the workup. The fix is often not thyroid replacement alone; restoring sex-hormone balance and immune function is frequently what lets the hypothalamic-pituitary-thyroid axis self-correct.

Body composition, read as a signal. The literature is consistent: both excess adiposity and being underweight raise infertility rates. This isn't about aesthetics or an arbitrary body mass index (BMI) cutoff - it's about what fat mass signals metabolically: inflammation, insulin resistance, altered sex-hormone metabolism, disrupted leptin signaling. The target is lean and fat mass in a range that supports metabolic function, not a number on a scale. Cross-reference the Metabolic Derailment guide if insulin resistance is part of your picture.

Cannabis and nicotine

The endocannabinoid system is directly involved in reproduction - CB1 and CB2 receptors are expressed on oocytes, the endometrium, and sperm - and regular cannabis use is associated with reduced ovulatory frequency, altered luteal characteristics, and lower implantation rates on the female side, with decreased count, motility, and morphology on the male side. Cannabidiol (CBD) isn't exempt for being non-intoxicating. It acts on several targets; one of them is inhibiting FAAH, the enzyme that clears anandamide, which can raise anandamide tone - and implantation depends on keeping that tone low at the right window. The anti-inflammatory case people reach for hasn't been shown to improve oocyte quality or implantation, the human reproductive-safety data are essentially absent, and chronic exposure impairs fertility in animal models. In the conception window it isn't the benign exception.

Smoking is well-established as a driver of accelerated ovarian aging - earlier menopause, lower AMH at any given age - and much of that follicle loss is a combustion effect: polycyclic aromatic hydrocarbons bind the aryl hydrocarbon receptor inside the oocyte and trigger programmed cell death, alongside cadmium and carbon monoxide, none of which are in vapor. Nicotine, though, isn't off the hook. The lab studies that show it shredding the oocyte's meiotic spindle use concentrations far above what a follicle sees - yet its inhibition of estrogen synthesis in the follicle shows up at the concentrations smokers carry, and it constricts blood vessels at everyday doses. The human data have since caught up: a large recent cohort (retrospective, over 20,000 women) found vaping itself lowered AMH - a reduced-reserve signal of its own, probably milder than smoke's. Vaping and pouches are plausibly less damaging than smoke, but 'less bad' is turning out to carry a measurable reserve cost, a long way from 'safe.' Stopping is still the sound call.

With both substances, the maturation windows set the stakes rather than a start date: an egg matures over roughly ninety days and sperm over about three months, so what stops now shows up in the eggs and sperm of the months ahead. That's a reason to stop now, alongside trying - never a reason to put off trying until the window has passed. One wrinkle: quitting nicotine is itself a short-term stressor. Acute withdrawal - irritability, disrupted sleep, craving - pulls on the same stress axis, a transient spike rather than a chronic strain; long term, coming off nicotine quiets that axis, and the transition is the hard part. A planned taper can soften the spike relative to stopping cold, and either one is worth starting now rather than timing around a cycle. For cannabis and nicotine alike, the question is whether the reproductive system is being asked to carry an avoidable burden.

Immune tolerance

An embryo is fifty percent genetically foreign, and the mechanism that keeps the maternal immune system from destroying it involves placental barrier function and a deliberate, coordinated dampening of non-self sensitivity. That process is imperfect, which is part of why autoimmune conditions - and even circulating autoantibodies such as antinuclear or antiphospholipid antibodies in the absence of diagnosable disease - can raise miscarriage rates. If you carry these antibodies - antiphospholipid in particular - that belongs with maternal-fetal medicine rather than managed alone: antiphospholipid syndrome is a treatable cause of recurrent loss, and the right protocol, typically low-dose aspirin with heparin, changes live-birth rates enough that identifying it matters. Longer cohabitation with unprotected sex with the same partner is associated with lower miscarriage and preeclampsia risk, a pattern attributed to developing tolerance to partner-specific antigens.

The visceral microbiomes

The gut microbiome's influence doesn't stay in the gut. A specific bacterial community - the estrobolome - produces beta-glucuronidase, which deconjugates estrogens in the intestinal lumen and sets how much is reabsorbed versus excreted. Dysbiosis there can skew estrogen recirculation toward estrogen excess relative to progesterone, with the clinical picture of heavy periods, worse premenstrual syndrome (PMS), and endometriosis or fibroid progression. There's also a distinct uterine microbiome - the endometrium isn't sterile - and a Lactobacillus-dominant environment is associated with better implantation and live-birth outcomes in IVF studies, while a non-Lactobacillus-dominant one correlates with implantation failure and recurrent miscarriage. The mechanism isn't fully mapped and likely involves local immune tolerance and the cytokine environment at the endometrial surface. This can't be fixed by gut probiotics alone; the uterine environment has its own composition and its own levers.

Testing exists for the endometrial piece. An endometrial microbiome and infectious-disease assessment (for example the EMMA/ALICE panel) evaluates uterine microbiome composition and the presence of chronic-endometritis pathogens, which show up in a meaningful share of women with unexplained implantation failure and go undetected on standard workup. Practically: support the gut with diverse plant fiber and fermented foods, work on known dysbiosis alongside trying, and consider the endometrial assessment specifically with a history of implantation failure or recurrent miscarriage.

What you carry

The external environment

The environment shapes the epigenome - not only of the pregnancy, but of the oocytes that precede it, because the eggs being recruited now have been accumulating environmental insults since before you were born. Pre-conception reduction of that burden is a mechanistically coherent intervention, and the highest-leverage moves are unglamorous.

Water

Whole-home filtration

The first thing to fix for anyone actively preparing for pregnancy. Common pollutants - pesticides, herbicides, pharmaceuticals, heavy metals - enter through what you drink and through skin contact while washing. A whole-house filter addresses both; if that's out of reach, at minimum a counter filter rated for pharmaceuticals, heavy metals, and common chemicals. The skin is the largest interface between you and the outside, so the water you wash with matters as much as the water you drink.

Air

HEPA filtration

Air pollution is a chronic, daily exposure. High-efficiency particulate air (HEPA) filtration in the home and workspace is a low-effort, meaningful reduction in total inhaled particulate and chemical exposure. The respiratory membranes are a major exchange surface - what gets in through the lungs reaches systemic circulation.

Fragrance

Synthetic fragrances

Perfume, scented candles, plug-in fresheners, scented detergent and dryer sheets, scented personal care. The "fragrance" designation is a labeling loophole that lets manufacturers combine dozens of undisclosed chemicals - frequently including phthalates, documented endocrine disruptors - under one proprietary term. The exposure is daily and enters through inhalation and skin at once. Switching to fragrance-free across personal care, cleaning, and laundry buys one of the largest exposure reductions available for the least effort.

Receipts

Thermal-paper receipts

The shiny receipts from gas pumps, restaurants, and retail counters are coated with bisphenol A (BPA) or bisphenol S (BPS), the chemical that develops the print. Skin contact transfers a measurable amount, and absorption increases substantially with hand-sanitizer or lotion residue on the skin. Decline the receipt or take the digital version; the exposure repeats with every receipt you handle.

The phthalate-fertility association is well-replicated at this point, including cohort data showing dose-dependent relationships between urinary phthalate metabolites and IVF outcomes - one of the cleaner exposure-outcome relationships in the reproductive literature. For those who want an objective read before conceiving, blood and urine xenobiotic testing is available; if the burden is high, supervised strategies - regular sweating through exercise or sauna, targeted nutraceuticals, or medical support - can help clear it before rather than after conception. Any of these clearance strategies belongs under provider oversight and isn't for use once pregnant.

The protocol

How to supplement

This protocol is built around the hormonal, metabolic, and cellular requirements the data best supports. The tiers stack: the foundation is the platform, the cellular and hormonal support sit on top of it, and a few items are indication-specific and belong under clinical oversight.

Check first. Review this protocol with the clinician who knows your history and your medications before you start it. If you take warfarin or another vitamin K antagonist, the K2 in the D3/K2 product works against the drug, and omega-3 at 2-4 g a day adds to the bleeding tendency of any anticoagulant or antiplatelet drug - check with your prescriber before either. Myo-inositol and N-acetylcysteine (NAC) improve insulin sensitivity, so on metformin or insulin a dose may need rechecking. DHEA and the estrogen-metabolism formula are a prescriber's call with a hormone-sensitive condition - a history of breast, ovarian, or endometrial cancer. Melatonin and DHEA are pre-conception only, and maca and the estrogen-metabolism formula aren't established as safe in pregnancy, so the whole protocol is worth a second review with your provider once a pregnancy is confirmed. Blood sugar in the diabetic range, antiphospholipid antibodies, and diminished ovarian reserve each put a clinician ahead of this protocol.

No supplement makes up for missing ground. The metabolic, stress, and environmental work is the ground; the foundation supplements are the platform; and the indication-specific items at the top belong only where the indication and a clinician warrant them.

The full protocol is available as a single Merlin-curated plan on Fullscript - Female Fertility, every product below in one click. Create an account in our dispensary at checkout and the plan comes in under list price. If you found this guide helpful, purchasing through it supports the work.View the plan →

Foundation

Prenatal multivitaminstart 3+ months ahead

A quality prenatal is the platform everything else sits on. Look for activated methyl folate rather than folic acid - the converting enzyme methylenetetrahydrofolate reductase (MTHFR) is commonly polymorphic and sluggish - iron as bisglycinate chelate rather than ferrous sulfate (non-constipating, better absorbed), iodine, and a full micronutrient and mineral panel. Start it now, alongside trying rather than ahead of it: folate's window for neural-tube development is the first trimester, often before a pregnancy is confirmed, so the sooner it's on board the better - and there's no reason to put off trying while it builds.

This is a case where the human evidence is unambiguous: pre-conception folate lowers the risk of neural-tube defects. It's the one supplement here that every guideline agrees on.

Prenatal Pro · Designs for Health

Omega-3 fatty acids2-4 g daily

Cell-membrane fluidity, inflammatory balance, and fetal neurodevelopment all draw on omega-3s. The fetal neurodevelopment data is robust and well-replicated; the fertility-outcome data is more mixed but generally positive across large meta-analyses. Docosahexaenoic acid (DHA) is the primary driver, so favor a product with a meaningful DHA fraction over an undifferentiated eicosapentaenoic acid (EPA)/DHA blend.

Designs for Health

Vitamin D3 / K2test, then dose

Vitamin D receptors are present in ovarian tissue, the endometrium, and the placenta, and deficiency is associated with reduced implantation and higher miscarriage risk. Reference range and functional target are different numbers: most labs flag deficiency below 20 ng/mL, while the target commonly used for reproductive function is closer to 50-70 ng/mL, which most people aren't reaching on 1,000-2,000 IU/day. Test rather than guess. K2, as menaquinone-7 (MK-7), is included to direct calcium toward bone rather than soft tissue. Vitamin K counteracts warfarin, so on warfarin or another vitamin K antagonist the K2 is for the prescriber to decide.

D3/K2 · practice store

Hormonal & metabolic support

Myo-inositol2-4 g daily, divided, with meals

Inositol is an intracellular signaling molecule that governs how insulin drives glucose disposal inside the cell. For reproduction it supports insulin sensitivity at the ovarian level, oocyte quality, and cell-membrane function. The evidence base in PCOS is the strongest - myo-inositol at 2-4 g/day performs comparably to metformin on several metabolic and hormonal parameters in multiple trials, without the gastrointestinal burden, though its effect on live birth specifically remains unproven. In women without PCOS the case is more supportive than proven, resting mainly on oocyte-quality and membrane rationale.

If a formulation uses the 40:1 myo-inositol to D-chiro-inositol ratio, that's the ratio found in healthy follicular fluid, and it's the one to lead with - myo-inositol dominance, not D-chiro. High-dose D-chiro-inositol alone can worsen oocyte quality. The PCOS guide works this same molecule in depth, and PCOS (now often termed Polyendocrine Metabolic Ovarian Syndrome, PMOS) is the most common ovulatory-infertility overlap this guide meets.

40:1 myo-inositol (MYO):D-chiro-inositol (DCI) formulation

Macacycle-phase dependent

Maca is a reproductive adaptogen described as a modulator that helps the HPO axis find its own homeostasis under strain rather than a blunt hormonal push. In the follicular phase it may act as a mild follicle-supportive agent at standard doses; across the cycle at lower maintenance doses it's used for stress-axis buffering. The human evidence is early and the mechanism isn't fully characterized, so treat the specifics as plausible rather than settled. Timing and dose are worth setting with a clinician before starting.

Femmenessence MacaHarmony · Symphony Natural Health

Estrogen-metabolism support (DIM / I3C)1 cap daily

A combination approach addressing oocyte quality, estrogen-metabolite balance, and redox status - typically diindolylmethane (DIM) and indole-3-carbinol (I3C) to shift estrogen metabolism toward weaker metabolites, calcium-d-glucarate to support estrogen clearance, plus green tea and antioxidant support. Most relevant for women with estrogen-dominant symptoms - heavy periods, fibroids, endometriosis, fibrocystic breasts. The rationale is mechanistic and the ingredients are individually studied; the combined fertility-outcome evidence is limited, so treat it as targeted support rather than a proven fertility treatment.

FemGuard + Balance · Designs for Health

DHEA25-75 mg daily · specific indication only

DHEA is not a general pre-conception supplement. Its use case is narrow: diminished ovarian reserve (low AMH, elevated day-3 FSH) or premature ovarian insufficiency, where it appears to support follicular response and oocyte quality through androgen-receptor signaling in the granulosa cells. The supporting trials are small and the effect is debated. Outside that indication the evidence doesn't support routine use, and excess androgen activity in women who don't need it carries its own consequences. DHEA requires clinical oversight and isn't for use once pregnant.

practice store · clinician-directed

Cellular & antioxidant support

Coenzyme Q10 (CoQ10, ubiquinol)200-600 mg daily

Mitochondrial function inside the oocyte is the energy source for meiosis and early embryonic division, and CoQ10 - specifically the reduced ubiquinol form - is a cofactor in the mitochondrial electron transport chain. Oocyte mitochondrial density and function decline with age, and trials in women over 35 and in poor responders to ovarian stimulation show improvements in oocyte quality and embryo development, though most are small and several sit within IVF cohorts. Its effect builds over the sixty to ninety days an egg takes to mature, so it's worth starting now.

ubiquinol · practice store

N-acetylcysteine (NAC)600-1200 mg daily

NAC is a glutathione precursor and one of the better-studied antioxidants in this context. Oxidative stress in the follicular environment degrades oocyte quality, and NAC supports the endogenous antioxidant system that manages that burden; it also has anti-inflammatory effects and can improve insulin sensitivity, which makes it particularly relevant in PCOS and endometriosis. The PCOS data includes improvements in ovulation and menstrual regularity across several trials, though the quality is moderate and it isn't a substitute for the metabolic groundwork.

practice store

Melatonin3 mg nightly · pre-conception only

Melatonin is present in follicular fluid at concentrations well above serum, functioning as a local antioxidant within the follicle rather than only a sleep signal, and IVF studies show improved oocyte and embryo quality with supplementation. It carries a firm caveat: melatonin is not established as safe during pregnancy, and this use is pre-conception only. Once pregnancy is confirmed, discontinue - and confirm timing with your provider before starting.

pre-conception only · discontinue when pregnant

Essential amino acidsdaily

Adequate protein is hard to maintain consistently, and the luteal phase in particular draws on circulating amino-acid pools to support endometrial proliferation and ovarian hormone signaling, with connective-tissue demand rising as pregnancy progresses. Starting essential amino-acid support in the pre-conception phase builds the substrate pool before it's needed rather than playing catch-up after implantation. It's insurance for the amino-acid pool rather than a targeted fertility agent, and the risk is low.

EAA formula · practice store

On the male side, the same levers apply. Sperm count, motility, morphology, and DNA fragmentation respond to most of the same inputs - omega-3s, CoQ10, antioxidant capacity, metabolic health, and reduced environmental exposure. The pre-conception protocol isn't gendered at the cellular level. Both partners get the workup and the supplementation. Paternal age carries its own contribution: de novo mutation rates rise with paternal age through a mechanism distinct from oocyte aging, so reproductive timing is a conversation for both partners. A Field Guide to Male Fertility carries the male-factor workup.

The panel

What to evaluate

Pre-conception blood work shows you what you're working with. The panel sets a baseline complete enough to act on, because most of what shows up is a collection of suboptimal readings that individually feel minor and collectively explain why nothing is working yet. The following is a reasonable baseline for a woman entering active pre-conception planning; a clinician will tailor it to your history.

Six reads on one system: ovarian and HPO, thyroid, metabolic, inflammatory, nutritional, and immune and toxin.

Cycle, HPO & androgens

Day-3 FSH LH Estradiol AMH Mid-luteal progesterone Total & free testosterone DHEA-S

Thyroid & metabolic

TSH Free T3 Free T4 Reverse T3 TPO antibodies Fasting insulin Fasting glucose HbA1c HOMA-IR

Inflammatory, nutritional & immune

hsCRP Homocysteine Vitamin D (25-OH) Ferritin RBC folate Methylmalonic acid Omega-3 index ANA Antiphospholipid Ab Urine xenobiotics

These are the core baseline for reading a pre-conception workup in context. Mid-luteal progesterone (day 19-21, or 7 days post-ovulation) is the one that confirms ovulation; the thyroid-stimulating hormone (TSH) target in the pre-conception window is tighter than the standard range, ideally below 2.5 mIU/L. Immune and xenobiotic panels are added on history.

No results to work from yet? FullMetrics / GeneMetrics runs panels deep enough to be worth reading.

The bottom line

A systems read, before the pregnancy

Pre-conception planning is a systems read on the internal and external conditions that decide whether a pregnancy can initiate, sustain, and develop well. Know your cycle well enough to predict it, and confirm ovulation with a mid-luteal progesterone. Track the hormones if you can. Get the blood work done and read the panel as a whole rather than waiting for a reference range that was never built for reproductive optimization to flag something.

Address the metabolic groundwork, the stress axis, and the environmental burden before the pregnancy, not reactively after. The supplement protocol buys coverage across the targets that matter most - oocyte quality, hormonal coordination, insulin sensitivity, antioxidant capacity, and the nutrient stores that conception and gestation draw on - while the ground does the heavy lifting underneath it.

This creates the conditions for fertility. It isn't an IVF or ovulation-induction program.

Appendix

Progesterone, the luteal phase, and pregnancy oversight

Low luteal-phase progesterone is both common and consequential. If the follicle wasn't large enough at rupture, or the corpus luteum can't sustain output, progesterone runs low and early pregnancy maintenance becomes difficult - which is especially relevant with a history of miscarriage, PCOS, or endometriosis. Tracking the mid-luteal rise, and continuing to check it early in a confirmed pregnancy, can be a meaningful measure. Oral progesterone support is straightforward for a clinician to add when there's a deficit - but it's a clinical decision, made on labs, under supervision, not a self-directed add-on.

Confirm ovulation before reading a luteal deficit. A mid-luteal serum progesterone (about 7 days post-ovulation, often day 19-21) is what establishes that an egg released and the corpus luteum is producing. A single LH strip can't stand in for this.
Progesterone support is prescriber-directed. Where a deficit is documented, oral or vaginal progesterone can support the luteal phase and early pregnancy - dosing, timing, and duration belong to the clinician managing the pregnancy.
Several supplements stop at conception. Melatonin and DHEA in this guide are pre-conception only; maca and the DIM / I3C estrogen-metabolism formula aren't established as safe once trying to conceive or pregnant. Review the whole protocol with your provider before you begin trying, and again once a pregnancy is confirmed.

Anything touching an active or attempted pregnancy belongs under a licensed clinician who has your history and your labs.

This guide is educational and isn't medical advice, diagnosis, or treatment. It doesn't replace the judgment of a licensed clinician who knows your history and your labs. Fertility care, hormone therapy, progesterone support, and related interventions are clinical decisions that carry real risks and require monitoring. Several supplements referenced here are pre-conception only and aren't for use once trying to conceive or pregnant without provider oversight; supplements can also interact with medications and conditions - review any protocol with your clinician before starting, particularly if you're managing a medical condition, taking prescription medication, trying to conceive, or pregnant. Biomarker panels listed here are illustrative, not exhaustive. Merlin may earn a commission on products purchased through the Fullscript plan linked here.

Read this against your own results. Bring what you have - any lab, any year, any provider. Your first month reads your results together, every result against every other, and starts you where it matters most.

Start your first month - $35

If you don't feel the value of Merlin after paying for your first month, tell us and we'll refund you in full. Monthly Core, once per person, by email within 30 days. The terms →

No results yet? Bring labs from anywhere, order our $180 baseline panel inside Merlin, or start with the questions, free.

Work with a practitioner. Some pictures want a second set of eyes and a plan you did not have to build yourself.

Start a conversation

~ Your health data is never used to train AI. ~